As of 2024-12-13, the EV/EBITDA ratio of agilon health Inc (AGL) is -2.78. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AGL's latest enterprise value is 801.41 mil USD. AGL's TTM EBITDA according to its financial statements is -288.28 mil USD. Dividing these 2 quantities gives us the above AGL EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 10.2x - 12.3x | 11.4x |
| Forward P/E multiples | 11.4x - 13.1x | 12.2x |
| Fair Price | (7.69) - (8.35) | (7.98) |
| Upside | -446.3% - -475.9% | -459.5% |
| Date | EV/EBITDA |
| 2024-12-09 | -2.81 |
| 2024-12-06 | -2.71 |
| 2024-12-05 | -2.77 |
| 2024-12-04 | -2.79 |
| 2024-12-03 | -2.65 |
| 2024-12-02 | -2.89 |
| 2024-11-29 | -2.59 |
| 2024-11-27 | -2.62 |
| 2024-11-26 | -2.54 |
| 2024-11-25 | -2.84 |
| 2024-11-22 | -2.31 |
| 2024-11-21 | -2.15 |
| 2024-11-20 | -1.99 |
| 2024-11-19 | -1.88 |
| 2024-11-18 | -1.85 |
| 2024-11-15 | -1.87 |
| 2024-11-14 | -2.05 |
| 2024-11-13 | -2.29 |
| 2024-11-12 | -2.28 |
| 2024-11-11 | -2.69 |
| 2024-11-08 | -2.24 |
| 2024-11-07 | -3.59 |
| 2024-11-06 | -3.72 |
| 2024-11-05 | -3.51 |
| 2024-11-04 | -3.42 |
| 2024-11-01 | -3.47 |
| 2024-10-31 | -3.25 |
| 2024-10-30 | -3.12 |
| 2024-10-29 | -3.21 |
| 2024-10-28 | -3.47 |
| 2024-10-25 | -3.29 |
| 2024-10-24 | -3.45 |
| 2024-10-23 | -3.45 |
| 2024-10-22 | -3.64 |
| 2024-10-21 | -3.62 |
| 2024-10-18 | -3.87 |
| 2024-10-17 | -4.32 |
| 2024-10-16 | -4.27 |
| 2024-10-15 | -4.35 |
| 2024-10-14 | -4.61 |
| 2024-10-11 | -4.21 |
| 2024-10-10 | -4.35 |
| 2024-10-09 | -4.07 |
| 2024-10-08 | -4.11 |
| 2024-10-07 | -4.11 |
| 2024-10-04 | -4.19 |
| 2024-10-03 | -4.12 |
| 2024-10-02 | -4.72 |
| 2024-10-01 | -4.85 |
| 2024-09-30 | -5.22 |